XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Collaboration agreement with AbbVie (Tables)
3 Months Ended
Mar. 31, 2024
Collaboration agreement with AbbVie  
Summarizes the change in deferred revenue

The following table summarizes the change in deferred revenue (in thousands):

Three Months Ended March 31, 2024

Balance as of December 31, 2023

$

15,982

Recognition of revenue

 

(1,029)

Balance as of March 31, 2024

$

14,953